GITNUX MARKETDATA REPORT 2024

Diversity In The Life Sciences Industry Statistics

Diversity in the life sciences industry statistics show a lack of representation of women and minority groups, highlighting the need for increased inclusion and equity initiatives.

Highlights: Diversity In The Life Sciences Industry Statistics

  • Women make up 45% of the entry-level workforce in life sciences, but only 20% of the executive committees in the same industry.
  • Ethnic minorities represent only about 14% of US biotechnology employees.
  • According to a 2017 study, women made up less than a third of the biotech workforce in the UK.
  • Men make up 69% of the life science industry workforce compared to 31% of women in Europe.
  • Approximately 60% of life sciences workers are over the age of 40.
  • Life science professionals with disabilities represent less than 1% of the workforce in this industry.
  • Among PhD graduates in life sciences, less than 10% of African Americans and Hispanics are employed in the industry.
  • In 2018, only 2.6% of Board of Director positions in biotechnology companies were held by ethnic minorities.
  • According to a survey by Liftstream, 13% of biotech companies have zero women in senior management roles.
  • Life sciences is the 6th least diverse sector, with pharmaceuticals and biotechnology performing particularly poorly in senior executive team diversity.
  • In 2015, only 1.6% of biotech CEOs in the top 20 pharmaceutical companies were women.
  • Over 52% of employees in the global biotechnology sector believe their companies need to do more to promote diversity.
  • Fewer than one in eight (12%) executive team members in the life sciences industry are from diverse ethnic backgrounds.
  • As few as 10% of pharmaceutical and medicine manufacturing CEO positions are held by women.
  • Only 30% of senior roles in the life sciences industry are held by women, a slight increase from 2018, when the figure was 29%.
  • In the United States, Black professionals make up only 5% of the life sciences industry.
  • In 2020, the percentage of women in biotech executive teams was only 17.9%.

Table of Contents

The Latest Diversity In The Life Sciences Industry Statistics Explained

Women make up 45% of the entry-level workforce in life sciences, but only 20% of the executive committees in the same industry.

This statistic highlights a significant gender disparity within the life sciences industry, revealing that while women account for almost half of the entry-level workforce, they are severely underrepresented at the executive level. This discrepancy suggests that there are systemic barriers or inequalities that prevent women from advancing into leadership positions within the industry. The lack of female representation in executive committees not only reflects a lack of diversity and inclusion within the sector but also raises concerns about gender equality and opportunities for career advancement for women in life sciences. Efforts to address this imbalance and promote gender diversity at all levels of the industry are crucial to ensuring a more equitable and inclusive workplace.

Ethnic minorities represent only about 14% of US biotechnology employees.

The statistic “Ethnic minorities represent only about 14% of US biotechnology employees” indicates that individuals from minority ethnic groups make up a relatively small proportion of the workforce in the biotechnology industry in the United States. This suggests a lack of diversity within the sector, with the majority of employees likely belonging to non-minority ethnic groups. This lack of representation can have implications for equity, inclusion, and the potential for diverse perspectives and experiences to contribute to innovation and success in the field. It may also highlight a need for increased efforts to promote diversity and inclusivity within the biotechnology industry to ensure a more representative and equitable workforce.

According to a 2017 study, women made up less than a third of the biotech workforce in the UK.

The statistic indicates that in 2017, women accounted for less than 33% of the workforce in the biotech industry in the United Kingdom. This data suggests a significant gender disparity within the sector, with a notable underrepresentation of women in biotechnology-related roles compared to their male counterparts. The lack of gender diversity in the biotech workforce may stem from various factors such as systemic barriers, cultural norms, or unequal opportunities. Addressing this imbalance is crucial for promoting inclusivity, diversity, and gender equality within the industry, which can lead to a more innovative and competitive biotech sector in the UK.

Men make up 69% of the life science industry workforce compared to 31% of women in Europe.

The statistic provided indicates that men outnumber women in the life science industry workforce in Europe, with men comprising 69% of the workforce compared to 31% for women. This gender disparity may suggest underlying inequalities or barriers for women in pursuing and advancing their careers in this particular sector. Factors such as gender bias in hiring practices, limited access to career development opportunities, or workplace cultures that may not be supportive of gender diversity could potentially contribute to this imbalance. Addressing these gender disparities and promoting opportunities for women in the life science industry is important for fostering a more inclusive and diverse workforce, which can lead to increased innovation and overall industry performance.

Approximately 60% of life sciences workers are over the age of 40.

The statistic that approximately 60% of life sciences workers are over the age of 40 suggests that a significant majority of individuals working in the life sciences industry fall into the older age demographic. This could have several implications for the industry, such as a potential shortage of younger talent entering the field or a need for targeted workforce development strategies to ensure continued growth and innovation. Additionally, the aging workforce may also indicate a wealth of experience and expertise within the industry, which can be valuable for mentoring and knowledge transfer. Overall, this statistic highlights the demographic composition of the life sciences workforce and raises important considerations for human resource planning and capacity building in the industry.

Life science professionals with disabilities represent less than 1% of the workforce in this industry.

The statistic “Life science professionals with disabilities represent less than 1% of the workforce in this industry” indicates a significant underrepresentation of individuals with disabilities within the life science sector. This statistic suggests a lack of diversity and inclusivity in the workforce, as well as potential barriers or challenges that may be hindering individuals with disabilities from entering or advancing in this industry. Addressing this disparity is crucial for promoting equity, diversity, and inclusion in the field of life sciences, as well as tapping into the valuable contributions that individuals with disabilities can bring to the sector through their skills, perspectives, and experiences. Efforts to increase the representation and support of professionals with disabilities in the life science industry can help create a more inclusive and thriving work environment for all.

Among PhD graduates in life sciences, less than 10% of African Americans and Hispanics are employed in the industry.

The statistic highlights a concerning disparity in the employment outcomes of African American and Hispanic PhD graduates in the life sciences industry, with less than 10% of these individuals securing jobs within the field. This suggests a significant underrepresentation of African Americans and Hispanics in the industry despite having earned advanced degrees in the relevant field. The data underscores the existence of systemic barriers or challenges that may be hindering the career advancement and opportunities for minority groups in the life sciences sector. Efforts to address these disparities and promote diversity and inclusion within the industry are crucial to ensure equal access to employment opportunities and to harness the diverse perspectives and talents of individuals from all backgrounds.

In 2018, only 2.6% of Board of Director positions in biotechnology companies were held by ethnic minorities.

The statistic that only 2.6% of Board of Director positions in biotechnology companies were held by ethnic minorities in 2018 indicates a significant lack of diversity within the leadership of the industry. This statistic suggests that there is a disproportionately low representation of ethnic minorities in decision-making roles within biotechnology companies, potentially resulting in limited perspectives and experiences being considered in critical business decisions. Addressing this disparity is crucial for promoting inclusivity, diversity, and equality within the industry and maximizing the potential for innovation and success.

According to a survey by Liftstream, 13% of biotech companies have zero women in senior management roles.

The statistic from Liftstream’s survey indicates that 13% of biotech companies do not have any women occupying senior management positions within their organizations. This finding highlights a lack of gender diversity at the leadership level in the biotech industry, suggesting potential barriers or challenges that may be preventing women from accessing or advancing into senior management roles within these companies. This underrepresentation of women in senior positions could have implications for decision-making processes, innovation, and overall organizational performance. Addressing this gender disparity in leadership roles is crucial for fostering a more inclusive and equitable workplace environment in the biotech sector.

Life sciences is the 6th least diverse sector, with pharmaceuticals and biotechnology performing particularly poorly in senior executive team diversity.

This statistic indicates that the life sciences sector ranks as the 6th least diverse industry in terms of representation across different demographic groups. Specifically, the senior executive teams in pharmaceuticals and biotechnology within the life sciences sector show a notable lack of diversity. This lack of diversity could imply limited representation of individuals from underrepresented groups at higher levels of leadership positions within these industries. Companies in the life sciences sector, particularly pharmaceuticals and biotechnology, may benefit from fostering more inclusive environments and actively promoting diversity to ensure a broader range of perspectives and experiences are brought to decision-making processes and organizational strategies.

In 2015, only 1.6% of biotech CEOs in the top 20 pharmaceutical companies were women.

The statistic “In 2015, only 1.6% of biotech CEOs in the top 20 pharmaceutical companies were women” suggests a significant gender disparity in leadership roles within the biotech industry. This figure highlights the underrepresentation of women in top executive positions, indicating a lack of gender diversity in the highest echelons of pharmaceutical companies. The statistic raises questions about the barriers and challenges faced by women in advancing their careers to leadership positions in the biotech sector. Addressing this gender gap is crucial not only for promoting equality and inclusivity but also for harnessing the diverse perspectives and talents that women bring to leadership roles, ultimately benefiting the industry as a whole.

Over 52% of employees in the global biotechnology sector believe their companies need to do more to
promote diversity.

The statistic highlights that a significant majority, specifically over 52% of employees within the global biotechnology sector, feel that their respective companies are falling short in promoting diversity. This suggests that there is a perceived gap between the current diversity initiatives within these biotechnology companies and the employees’ expectations. The statistic underscores the importance of fostering more inclusive work environments within the biotechnology sector to better reflect the diverse world we live in. It also signals a potential need for companies to re-evaluate their diversity and inclusion efforts to ensure that they are effectively engaging and supporting employees from various backgrounds and perspectives.

Fewer than one in eight (12%) executive team members in the life sciences industry are from diverse ethnic backgrounds.

The statistic suggests that representation of individuals from diverse ethnic backgrounds within the executive teams of companies in the life sciences industry is limited, with less than one in eight (12%) members being from diverse ethnic backgrounds. This implies a lack of diversity at the highest levels of leadership in the industry, which could potentially hinder innovation, decision-making, and overall performance of the organizations. Increasing diversity within executive teams has been shown to bring different perspectives, experiences, and ideas to the table, which can lead to improved strategic planning, increased creativity, and better understanding of diverse markets and customers. Addressing this lack of diversity could be crucial for fostering a more inclusive and innovative culture within the life sciences industry.

As few as 10% of pharmaceutical and medicine manufacturing CEO positions are held by women.

The statistic indicates that there is a lack of gender diversity in top leadership positions within the pharmaceutical and medicine manufacturing industry, with only 10% of CEO roles being held by women. This underrepresentation of women in executive positions suggests potential barriers and challenges that women face in accessing and advancing into leadership roles within the industry. The statistic raises important questions about gender equality, diversity, and inclusion efforts within the pharmaceutical sector, highlighting the need for organizations to address systemic obstacles and create more gender-balanced leadership teams to drive innovation and success in the industry.

Only 30% of senior roles in the life sciences industry are held by women, a slight increase from 2018, when the figure was 29%.

The statistic states that only 30% of senior roles in the life sciences industry are filled by women, indicating a gender disparity in leadership positions within the sector. The slight increase from 29% in 2018 suggests a slow progression towards gender parity but also highlights the ongoing challenges women face in achieving senior leadership positions in this particular industry. This statistic underscores the need for continued efforts to promote diversity, inclusion, and gender equality in the life sciences field to ensure that talented individuals, regardless of gender, have equal opportunities to advance and excel in their careers.

In the United States, Black professionals make up only 5% of the life sciences industry.

The statistic that Black professionals make up only 5% of the life sciences industry in the United States indicates a significant underrepresentation of Black individuals within this sector. This lack of diversity within the life sciences industry can have far-reaching implications, including limited perspectives, missed opportunities for innovation, and potential barriers for career advancement for Black professionals. Addressing this disparity is crucial not only for creating a more inclusive and equitable workforce but also for driving impactful advancements in life sciences research and development. Strategies to increase representation and support for Black professionals in this industry are essential to harnessing the full potential of diverse talent and fostering a more dynamic and successful life sciences sector.

In 2020, the percentage of women in biotech executive teams was only 17.9%.

The statistic indicates that in the field of biotechnology, in the year 2020, women were underrepresented in executive positions, accounting for only 17.9% of the total executive teams. This percentage suggests a disparity in gender representation within leadership roles in the biotech industry, where women are significantly outnumbered by their male counterparts. The low percentage of women in biotech executive teams may reflect underlying systemic barriers or biases that hinder women’s career advancement opportunities within the industry. Addressing this gender imbalance is essential for promoting diversity, equity, and inclusivity in the biotech sector and unlocking the full potential of talented individuals regardless of gender.

References

0. – https://www.www.liftstream.com

1. – https://www.www.bio.org

2. – https://www.www.catalyst.org

3. – https://www.www.statista.com

4. – https://www.www.ncbi.nlm.nih.gov

5. – https://www.fortune.com

6. – https://www.www.pwc.com

7. – https://www.www.hbanet.org

8. – https://www.www.nature.com

9. – https://www.www.futureofbusinessandtech.com

10. – https://www.www.corex-depot.com

11. – https://www.www.lifescienceintegrates.com

12. – https://www.www.mckinsey.com

How we write our statistic reports:

We have not conducted any studies ourselves. Our article provides a summary of all the statistics and studies available at the time of writing. We are solely presenting a summary, not expressing our own opinion. We have collected all statistics within our internal database. In some cases, we use Artificial Intelligence for formulating the statistics. The articles are updated regularly.

See our Editorial Process.

Table of Contents

... Before You Leave, Catch This! 🔥

Your next business insight is just a subscription away. Our newsletter The Week in Data delivers the freshest statistics and trends directly to you. Stay informed, stay ahead—subscribe now.

Sign up for our newsletter and become the navigator of tomorrow's trends. Equip your strategy with unparalleled insights!